| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
325,886 |
282,018 |
$14.02M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
95,463 |
84,441 |
$5.37M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
168,630 |
150,964 |
$4.26M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
65,672 |
59,256 |
$4.07M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
62,285 |
56,805 |
$3.55M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
54,467 |
50,273 |
$3.37M |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
40,586 |
36,774 |
$2.69M |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
135,410 |
121,216 |
$1.74M |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
22,081 |
19,654 |
$1.57M |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
6,103 |
5,373 |
$1.42M |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
11,405 |
9,188 |
$1.26M |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
84,680 |
77,301 |
$1.17M |
| 54150 |
|
6,712 |
6,195 |
$835K |
| 92551 |
|
105,331 |
96,140 |
$753K |
| 99051 |
|
44,191 |
40,048 |
$690K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
12,434 |
11,738 |
$637K |
| 99233 |
Prolong inpt eval add15 m |
20,396 |
6,141 |
$611K |
| 99205 |
Prolong outpt/office vis |
4,848 |
3,896 |
$494K |
| 99460 |
|
11,294 |
10,686 |
$494K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
15,340 |
13,853 |
$460K |
| 93320 |
|
11,480 |
9,247 |
$456K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
2,221 |
2,055 |
$448K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
10,757 |
9,212 |
$420K |
| 99223 |
Prolong inpt eval add15 m |
6,463 |
5,127 |
$406K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
4,502 |
3,750 |
$352K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
3,365 |
2,946 |
$348K |
| 93325 |
|
12,871 |
10,113 |
$335K |
| 99188 |
|
17,233 |
14,884 |
$325K |
| 99215 |
Prolong outpt/office vis |
4,761 |
3,879 |
$314K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
5,094 |
4,525 |
$275K |
| 87634 |
|
5,085 |
4,191 |
$251K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
9,422 |
1,791 |
$245K |
| 90474 |
|
28,067 |
25,150 |
$226K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
63,579 |
49,262 |
$219K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
3,615 |
3,217 |
$216K |
| 99173 |
|
118,607 |
104,542 |
$194K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
5,036 |
4,270 |
$171K |
| 96160 |
|
21,452 |
17,285 |
$166K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,348 |
6,781 |
$163K |
| 99462 |
|
6,763 |
5,024 |
$159K |
| T1015 |
Clinic visit/encounter, all-inclusive |
6,309 |
2,981 |
$157K |
| 93000 |
|
10,780 |
9,286 |
$143K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
830 |
736 |
$140K |
| 99385 |
|
2,125 |
1,805 |
$124K |
| 99220 |
|
1,531 |
1,319 |
$119K |
| 97802 |
|
104,895 |
77,009 |
$110K |
| 98960 |
|
34,527 |
18,183 |
$95K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
3,509 |
3,171 |
$95K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
18,003 |
14,157 |
$87K |
| 83655 |
|
9,312 |
7,639 |
$86K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,831 |
7,178 |
$85K |
| 99401 |
|
7,518 |
6,234 |
$85K |
| 94060 |
|
2,242 |
1,992 |
$80K |
| 69210 |
|
4,058 |
2,168 |
$79K |
| 99386 |
|
1,021 |
883 |
$71K |
| 99381 |
|
837 |
724 |
$46K |
| 90473 |
|
4,900 |
4,137 |
$41K |
| 99222 |
Initial hospital care, per day, moderate complexity |
597 |
493 |
$40K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
495 |
137 |
$36K |
| 95117 |
|
4,206 |
2,562 |
$36K |
| 96127 |
|
35,982 |
25,179 |
$35K |
| 96161 |
|
7,249 |
5,496 |
$35K |
| 0001A |
|
881 |
750 |
$32K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
552 |
507 |
$32K |
| 0002A |
|
862 |
699 |
$30K |
| 97803 |
|
46,898 |
37,471 |
$29K |
| 99219 |
|
337 |
326 |
$28K |
| 0071A |
|
702 |
563 |
$26K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
281 |
265 |
$26K |
| 80053 |
Comprehensive metabolic panel |
2,964 |
2,462 |
$23K |
| 76825 |
|
285 |
221 |
$23K |
| 76820 |
|
623 |
447 |
$22K |
| 87807 |
|
1,767 |
1,612 |
$20K |
| 99225 |
|
871 |
637 |
$20K |
| G9919 |
Screening performed and positive and provision of recommendations |
704 |
663 |
$19K |
| 0072A |
|
453 |
410 |
$19K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
5,353 |
4,118 |
$18K |
| 95115 |
|
2,069 |
959 |
$14K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,507 |
1,347 |
$14K |
| 80061 |
Lipid panel |
1,651 |
1,307 |
$14K |
| 76827 |
|
314 |
245 |
$13K |
| 90686 |
|
27,208 |
23,538 |
$11K |
| 81025 |
|
2,172 |
1,876 |
$10K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
3,707 |
2,495 |
$10K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
1,621 |
1,353 |
$10K |
| 90682 |
|
272 |
213 |
$9K |
| 36415 |
Collection of venous blood by venipuncture |
5,256 |
4,611 |
$8K |
| 92567 |
|
792 |
655 |
$8K |
| 81003 |
|
6,592 |
4,931 |
$8K |
| 93227 |
|
408 |
310 |
$7K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
634 |
583 |
$7K |
| 85018 |
|
6,897 |
5,250 |
$7K |
| 93304 |
|
90 |
69 |
$6K |
| 17110 |
|
74 |
62 |
$4K |
| 99226 |
|
190 |
111 |
$4K |
| 99383 |
|
71 |
52 |
$4K |
| 86308 |
|
740 |
701 |
$3K |
| 93244 |
|
183 |
167 |
$3K |
| 93225 |
|
414 |
303 |
$3K |
| G0445 |
High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes |
1,269 |
801 |
$3K |
| 96380 |
|
203 |
179 |
$3K |
| 99050 |
|
232 |
206 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,229 |
870 |
$2K |
| 82947 |
|
1,107 |
848 |
$2K |
| 99406 |
|
883 |
508 |
$2K |
| 99407 |
|
227 |
164 |
$2K |
| 93242 |
|
182 |
166 |
$2K |
| 0513F |
|
1,425 |
1,211 |
$2K |
| 94760 |
|
24,227 |
16,643 |
$1K |
| 85651 |
|
554 |
419 |
$1K |
| 93248 |
|
61 |
59 |
$1K |
| 0011A |
|
52 |
43 |
$1K |
| 0081A |
|
44 |
30 |
$1K |
| 99384 |
|
12 |
12 |
$1K |
| 93321 |
|
52 |
40 |
$1K |
| 3074F |
|
3,513 |
3,081 |
$846.00 |
| 90672 |
|
6,125 |
4,978 |
$800.80 |
| 3079F |
|
2,753 |
2,407 |
$774.00 |
| 17250 |
|
17 |
13 |
$754.64 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
30 |
24 |
$735.70 |
| 3077F |
|
2,625 |
2,194 |
$705.28 |
| 3078F |
|
3,286 |
2,855 |
$700.00 |
| 0082A |
|
20 |
18 |
$664.65 |
| 90670 |
|
36,456 |
31,607 |
$663.67 |
| 93246 |
|
61 |
59 |
$657.34 |
| 90621 |
|
3,797 |
3,185 |
$538.31 |
| 90715 |
|
3,642 |
3,078 |
$510.56 |
| 3080F |
|
1,709 |
1,461 |
$504.28 |
| G0180 |
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
67 |
61 |
$488.27 |
| 31720 |
|
22 |
17 |
$473.69 |
| 90656 |
|
1,199 |
1,077 |
$471.87 |
| 90651 |
|
11,506 |
9,901 |
$435.42 |
| 3075F |
|
1,580 |
1,404 |
$399.00 |
| 90688 |
|
322 |
131 |
$361.92 |
| 99177 |
|
231 |
169 |
$325.43 |
| 93272 |
|
17 |
14 |
$305.00 |
| 0012A |
|
20 |
16 |
$298.86 |
| 90677 |
|
373 |
346 |
$288.66 |
| 90732 |
|
31 |
25 |
$266.94 |
| 90734 |
|
6,332 |
5,426 |
$250.29 |
| 80305 |
|
71 |
26 |
$237.38 |
| 81000 |
|
146 |
106 |
$236.26 |
| 3044F |
|
76 |
64 |
$190.00 |
| 82247 |
|
51 |
40 |
$180.19 |
| 90697 |
|
10,487 |
9,120 |
$150.00 |
| 93040 |
|
58 |
30 |
$135.73 |
| H0049 |
Alcohol and/or drug screening |
35 |
25 |
$61.25 |
| 36416 |
|
2,567 |
1,886 |
$37.94 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
60 |
57 |
$35.13 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
104 |
77 |
$20.00 |
| 90744 |
|
13,382 |
11,697 |
$18.26 |
| 90698 |
|
27,641 |
23,768 |
$14.70 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
66 |
41 |
$13.48 |
| 91300 |
|
1,839 |
1,460 |
$11.27 |
| 90680 |
|
27,479 |
23,544 |
$9.13 |
| 90633 |
|
25,961 |
21,957 |
$5.87 |
| 90671 |
|
9,111 |
7,807 |
$0.02 |
| 90707 |
|
5,673 |
4,908 |
$0.00 |
| 90710 |
|
4,473 |
3,817 |
$0.00 |
| 4001F |
|
32 |
31 |
$0.00 |
| 90700 |
|
1,475 |
1,314 |
$0.00 |
| 90685 |
|
4,114 |
3,775 |
$0.00 |
| 3015F |
|
581 |
519 |
$0.00 |
| 3511F |
|
254 |
242 |
$0.00 |
| 3016F |
|
1,491 |
1,348 |
$0.00 |
| 90648 |
|
261 |
230 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
107 |
68 |
$0.00 |
| 1159F |
|
1,226 |
1,091 |
$0.00 |
| 1160F |
|
1,226 |
1,091 |
$0.00 |
| 90380 |
|
13 |
12 |
$0.00 |
| 90681 |
|
92 |
82 |
$0.00 |
| 91308 |
|
107 |
80 |
$0.00 |
| 90696 |
|
4,127 |
3,528 |
$0.00 |
| 90619 |
|
5,879 |
4,821 |
$0.00 |
| 99000 |
|
1,803 |
1,169 |
$0.00 |
| 90716 |
|
5,758 |
4,985 |
$0.00 |
| 1034F |
|
186 |
168 |
$0.00 |
| 90723 |
|
779 |
736 |
$0.00 |
| 90381 |
|
135 |
119 |
$0.00 |
| 90647 |
|
1,713 |
1,608 |
$0.00 |
| 99024 |
|
68 |
54 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
73 |
67 |
$0.00 |
| 1000F |
|
1,425 |
1,273 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
258 |
197 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
105 |
85 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
496 |
424 |
$0.00 |
| 1036F |
|
1,291 |
1,147 |
$0.00 |
| 97804 |
|
168 |
140 |
$0.00 |
| 90660 |
|
554 |
448 |
$0.00 |
| 3017F |
|
30 |
30 |
$0.00 |
| 91307 |
|
1,428 |
1,184 |
$0.00 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
157 |
92 |
$0.00 |
| 4000F |
|
158 |
143 |
$0.00 |
| 3014F |
|
92 |
86 |
$0.00 |
| 3048F |
|
15 |
14 |
$0.00 |
| 3008F |
|
342 |
325 |
$0.00 |
| 91305 |
|
35 |
26 |
$0.00 |
| 91301 |
|
80 |
75 |
$0.00 |
| 99217 |
|
139 |
101 |
$0.00 |
| 4010F |
|
93 |
82 |
$0.00 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
14 |
12 |
$0.00 |
| 3049F |
|
21 |
19 |
$0.00 |